In the past 10 years, specific roles of peroxisome proliferator-activated receptor (PPAR) alpha and PPAR-gamma have emerged as important determinants of vascular function and structure. Although PPAR-delta (also known as PPAR-beta and NUC-l) is widely expressed in many tissues, the role of PPAR-delta is poorly understood. Our preliminary studies have documented for the first time that PPAR-delta is expressed in vascular smooth muscle cells (VSMCs) and up-regulated after vascular injury. In addition, we demonstrated that stable over expression of PPAR-delta in rat VSMC promotes cell proliferation. Furthermore, we observed that PDGF and TNF-alpha up-regulate PPAR-delta gene expression in VSMC. These intriguing results indicate that the up-regulation of PPAR-delta gene expression may play an important role during vascular lesion formation. The proposed project will test the central hypothesis that cytokines and growth factors expressed in response to vascular injury induce an up-regulation of PPAR-delta expression; the increase in this transcription factor may promote neointima formation by increasing VSMC proliferation.
Our specific aims are: 1) Determine the transcriptional regulatory mechanisms by which TNF-alpha and PDGF induce PPAR-delta gene expression in VSMC, 2) Determine the mediator role of PPAR-delta in the regulation of VSMC proliferation in cell culture models, and 3) Determine the mediator role of PPAR-delta as an endogenous promoter of lesion formation in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Minority Biomedical Research Support - MBRS (S06)
Project #
2S06GM008248-16
Application #
6547663
Study Section
Special Emphasis Panel (ZGM1)
Project Start
1987-09-30
Project End
2006-07-31
Budget Start
Budget End
Support Year
16
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Morehouse School of Medicine
Department
Type
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
30310
Wilson, Nana O; Solomon, Wesley; Anderson, Leonard et al. (2013) Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One 8:e60898
Igietseme, Joseph U; Omosun, Yusuf; Partin, James et al. (2013) Prevention of Chlamydia-induced infertility by inhibition of local caspase activity. J Infect Dis 207:1095-104
Wilson, Nana; Driss, Adel; Solomon, Wesley et al. (2013) CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria. PLoS One 8:e81329
Kim, Teayoun; Zhelyabovska, Olga; Liu, Jian et al. (2013) Generation of an inducible, cardiomyocyte-specific transgenic mouse model with PPAR ?/? overexpression. Methods Mol Biol 952:57-65
Shelton, Martin N; Huang, Ming-Bo; Ali, Syed A et al. (2012) Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J Virol 86:406-19
Campbell, Patrick E; Isayev, Olexandr; Ali, Syed A et al. (2012) Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling. J Mol Model 18:4603-13
Liu, Mingli; Amodu, Audu S; Pitts, Sidney et al. (2012) Heme mediated STAT3 activation in severe malaria. PLoS One 7:e34280
Wilson, Nana O; Ceesay, Fatou K; Hibbert, Jacqueline M et al. (2012) Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study. Am J Trop Med Hyg 86:936-42
Wilson, Nana O; Ceesay, Fatou K; Obed, Samuel A et al. (2011) Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. Am J Trop Med Hyg 85:12-21
Lucchi, Naomi W; Jain, Vidhan; Wilson, Nana O et al. (2011) Potential serological biomarkers of cerebral malaria. Dis Markers 31:327-35

Showing the most recent 10 out of 122 publications